Detection of ESBL-producing clinical isolates of gram negative bacilli and their antibiotic resistance in Shantou
10.3760/cma.j.issn.1008-6706.2011.12.001
- VernacularTitle:产超广谱β-内酰胺酶革兰阴性杆菌的检测和耐药性研究
- Author:
Bin HUANG
;
Shengbin ZHANG
;
Linhuan HUANG
;
Hongjun ZHU
;
Zhaohui LIU
;
Ziwen ZHAO
;
Canmao XIE
- Publication Type:Journal Article
- Keywords:
Escherichia coli;
Klebsiella pneumonia;
Extended-spectrum beta-lactamases;
Antibiotic resistance
- From:
Chinese Journal of Primary Medicine and Pharmacy
2011;18(12):1585-1586
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the extended-spectrum beta-lactamases ( ESBLs) producing clinical isolates of gram negative bacilli and their antibiotic resistance in Shantou and to provide suggestions on empirical treatment against the bacteria.Methods A total of 1 445 strains of gram negative bacilli (895 strains of Escherichia coli and 550 strains of Klebsiella pneumonia) were collected and examined for the production of ESBLs and antibacterial susceptibility test by Vitek-2.Results There were 69.4% of escherichia coli and 33.6% of klebsiella pneumonia producing ESBLs.The resistance rate of the ESBLs-producing strains to penicillins,cephalosporins and monocyclic beta-lactam antibiotics were very high.The ESBLs-producing strains were multidrug resistant and the resistance rates were higher than that of the non-ESBLs-producing strains.Both ESBLs-producing and non-ESBLs-producing strains were susceptible to Imipenem.Conclusion The incidence of ESBLs-producing strains was high in gram negative bacilli in Shantou.The resistance rates of the ESBLs-producing strains were higher than that of the non-ESBLs-producing strains and they expressed multiple drug resistance phenotypes.Imipenem was the best drug in the treatment of infections caused by ESBLs-producing strains.
